Molecular genetics of cryptorchidism

References:

1 鲍倩,张文.小儿隐睾的诊断标准与治疗方案[J].实用儿科临床杂志,2012,27(23):1847-1848.DOI:10.3969/j.issn.1003-515X.2012.23.026. Bao Q,Zhang W.Diagnostic criteria and treatment for cryptorchidism[J].J Appl Clin Pediatr,2012,27(23):1847-1848.DOI:10.3969/j.issn.1003-515X.2012.23.026.
2 Kuiri-Hanninen T,Koskenniemi J,Dunkel L,et al.Postnatal testicular activity in healthy boys and boys with cryptorchidism[J].Front Endocrinol,2019,10:489.DOI:10.3389/fendo.2019.00489.
3 Lane C,Boxall J,MacLellan D,et al.A population-based study of prevalence trends and geospatial analysis of hypospadias and cryptorchidism compared with non-endocrine mediated congenital anomalies[J].J PediatrUrol,2017,13(3):284.e1-e7.DOI:10.1016/j.jpurol.2017.02.007.
4 Virtanen HE,Toppari J.Cryptorchidism and fertility[J].Endocrinol Metab Clin North Am,2015,44(4):751-760.DOI:10.1016/j.ecl.2015.07.013.
5 Komarowska MD,Hernanowicz A,Debek W.Putting the pieces together:cryptorchidism-do we know everything?[J].J Pediatr Endocrinol Metab,2015,28(11-12):1247-1256.DOI:10.1515/jpem-2015-0098.
6 Hutson JM,Southwell BR,Li R,et al.The regulation of testicular descent and the effects of cryptorchidism[J].Endocr Rev,2013,34(5):725-752.DOI:10.1210/er.2012-1089.
7 Gurney JK,McGlynn KA,Stanley J,et al.Risk factors for cryptorchidism[J].Nat Rev Urol,2017,14(9):534-548.DOI:10.1038/nrurol.2017.90.
8 Kojima Y,Mizuno K,Kohri K,et al.Advances in molecular genetics of cryptorchidism[J].Urology,2009,74(3):571-578.DOI:10.1016/j.urology.2009.04.037.
9 Koskenniemi JJ,Virtanen HE,Wohlfahrt-Veje C,et al.Postnatal changes in testicular position are associated with IGF-1 and function of sertoli and leydig cells[J].J Clin Endocrinol Metab,2018,103(4):1429-1437.DOI:10.1210/jc.2017-01889.
10 赵丽丽,聂敏,伍学焱.胰岛素样肽3的功能及其研究进展[J].生殖医学杂志,2016, 25(4):374-377.DOI:10.3969/j.issn.1004-3845.2016.04.017. Zhao L,Nie M,Wu X.Function insulin-like peptide 3 and its research advances[J].J Reprod Med,2016,25(4):374-377.DOI:10.3969/j.issn.1004-3845.2016.04.017.
11 Kong RC,Shilling PJ,Lobb DK,et al.Membrane receptors:structure and function of the relaxin family peptide receptors[J].Mol Cell Endocrinol,2010,320(1-2):1-15.DOI:10.1016/j.mce.2010.02.003.
12 Song XF,Wei GH,Liu X,et al.Effects of diethylhexylphthalate (DEHP) on INSL-3 mRNA expression by Leydig cells derived from mouse embryos and in newborn mice[J].J Int Med Res,2008,36(3):512-521.DOI:10.1177/147323000803600316.
13 茅江峰.不同基因突变对特发性低促性腺激素性性腺功能减退症患者的临床特点、隐睾和生精疗效的影响[D].北京协和医学院;中国医学科学院;清华大学医学部,2013. Mao JF.Clinical features of different genetic mutations in patients with idiopathic hypogonadotropic hypogonadism,cryptorchidism and spermatogenic effect[D].Peking Union Medical College Hospital,Chinese Academy of Medical Sciences;College of Medicine,Qsinghua University,2013.
14 WangY,Gong C,Qin M,et al.Clinical and genetic features of 46 young male paediatric patients with congenital hypogonadotropic hypogonadism[J].Clin Endocrinol (Oxf),2017,87(6):757-766.DOI:10.1111/cen.13451.
15 Laitinen EM,Tommiska J,Virtanen HE,et al.Isolated cryptorchidism:no evidence for involvement of genes underlying isolated hypogonadotropic hypogonadism[J].Mol Cell Endocrinol,2011,341(1-2):35-38.DOI:10.1016/j.mce.2011.05.015.
16 Ben HH,Mougou-Zerelli S,Hadded A,et al.Novel homozygous nonsense mutations in the luteinizing hormone receptor (LHCGR) gene associated with 46,XY primary amenorrhea[J].Fertil Steril,2016,106(1):225-229.DOI:10.1016/j.fertnstert.2016.03.008.
17 Pandey AV,Sproll P.Pharmacogenomics of human P450 oxidoreductase[J].Front Pharmacol,2014,5:103.DOI:10.3389/fphar.2014.00103.
18 Werner R,Kulle A,Sommerfeld I,et al.Testosterone synthesis in patients with 17β-hydroxysteroid dehydrogenase 3 deficiency[J].Sex Dev,2012,6(4):161-168.DOI:10.1159/000336605.
19 宋艳宁,陈佳佳,巩纯秀.17β-羟类固醇脱氢酶3型缺乏症2例并文献复习[J].中华实用儿科临床杂志,2018,33(8):618-620.DOI:10.3760/cma.j.issn.2095-428X.2018.08.015. Song YN,Chen JJ,Gong CX.Two case of 17β-hydroxysteroid dehydrogenase 3 deficiency and literature review[J].Chin J Appl Clin Pediatr,2018,33(8):618-620.DOI:10.3760/cma.j.issn.2095-428X.2018.08.015.
20 Barthold JS,Kumasi-Rivers K,Upadhyay J,et al.Testicular position in the androgen insensitivity syndrome:implications for the role of androgens in testicular descent[J].J Urol,2000,164(2):497-501.
21 WangY,Gong C,Wang X,et al.AR mutations in 28 patients with androgen insensitivity syndrome (Prader grade 0-3)[J].Sci China Life Sci,2017,60(7):700-706.DOI:10.1007/s11427-017-9084-9.
22 Ferlin A,Vinanzi C,Garolla A,et al.Male infertility and androgen receptor gene mutations:clinical features and identification of seven novel mutations[J].Clin Endocrinol (Oxf),2006,65(5):606-610.DOI:10.1111/j.1365-2265.2006.02635.x.
23 Gui B,Song Y,Su Z,et al.New insights into 5α-reductase type 2 deficiency based on a multi-centre study:regional distribution and genotype-phenotype profiling of SRD5A2 in 190 Chinese patients[J].J Med Genet,2019,56(10):685-692.DOI:10.1136/jmedgenet-2018-105915.
24 高攀,张贤生.隐睾症发病的内分泌分子病因学研究进展[J].中国男科学杂志,2015,29:67-72.DOI:10.3969/j.issn.1008-0848.2015.06.016. Gao P,Zhang XS.Research advances in the molecular endocrinological etiology cryptorchidism[J].Chinese Journal of Andrology,2015,29:67-72.DOI:10.3969/j.issn.1008-0848.2015.06.016
25 Hermanowicz A,Matuszczak E,Debek W,et al.Expression of estrogen receptors α and β in paratesticular tissues in boys operated on for unilateral cryptorchidism between the 1st and 4th years of life[J].Med Sci Monit,2012,18(10):CR630-CR634.DOI:10.12659/msm.883490.
26 Mizuno K,Kojima Y,Kurokawa S,et al.Altered expression and localization of estrogen receptors alpha and beta in the testes of a cryptorchid rat model[J].Urol,2011,77(1):251.e1-e6.DOI:10.1016/j.urology.2010.06.035.
27 Bay K,Andersson AM.Human testicular insulin-like factor 3:in relation to development,reproductive hormones and andrological disorders[J].Int J Androl,2011,34(2):97-109.DOI:10.1111/j.1365-2605.2010.01074.x.
28 Zuccarello D,Morini E,Douzgou S,et al.Preliminary data suggest that mutations in the CgRP pathway are not involved in human sporadic cryptorchidism[J].J Endocrinol Invest,2004,27(8):760-764.DOI:10.1007/BF03347519.
29 Foresta C,Zuccarello D,Garolla A,et al.Role of hormones,genes,and environment in human cryptorchidism[J].Endocr Rev,2008,29(5):560-580.DOI:10.1210/er.2007-0042.
30 Picard JY,Cate RL,Racine C,et al.The persistent mullerian duct syndrome:an update based upon a personal experience of 157 cases[J].Sex Dev,2017,11(3):109-125.DOI:10.1159/000475516.
31 Ren XY,Wu D,Gong CX.A case of Persistent Müllerian Duct Syndrome and the Literature Review[J].Exp Ther Med,2017,14(6):5779-5784.DOI:10.3892/etm.2017.5281.
32 White JJ,Mazzeu JF,Coban-Akdemir Z,et al.WNT signaling perturbations underlie the genetic heterogeneity of Robinow syndrome[J].Am J Hum Genet,2018,102(1):27-43.DOI:10.1016/j.ajhg.2017.10.002.
33 Ahmed A,Mufeed A,Ramachamparambathu AK,et al.Identifying Aarskog syndrome[J].J Clin Diagn Res,2016,10(12):ZD09-ZD11.DOI:10.7860/JCDR/2016/22180.8982.
34 Yart A,Edouard T.Noonan syndrome:an update on growth and development[J].Curr Opin Endocrinol Diabetes Obes,2018,25(1):67-73.DOI:10.1097/MED.0000000000000380.
35 Moatamedi M,Derakhshan M.LEOPARD syndrome:a case report and literature review[J].Clin Med (Lond),2019,19(Suppl 3):23.DOI:10.7861/clinmedicine.19-3-s23.
36 Kline AD,Moss JF,Selicorni A,et al.Diagnosis and management ofCornelia de Lange syndrome:first International consensus statement[J].Nat Rev Genet,2018,19(10):649-666.DOI:10.1038/s41576-018-0031-0.
37 Milani D,Manzoni FM,Pezzani L,et al.Rubinstein-Taybi syndrome:clinical features,genetic basis,diagnosis and management[J].Ital J Pediatr,2015,41,4.DOI:10.1186/s13052-015-0110-1.